Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Apr 30, 2024 (filed on May 02, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-629Price:$126.25
-
Apr 15, 2024 (filed on Apr 16, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,990Price:$137.81
-
Apr 08, 2024 (filed on Apr 10, 2024)Insider Name:Sayer Kevin ROwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-22,361Price:$138.71
-
Apr 08, 2024 (filed on Apr 10, 2024)Insider Name:Sayer Kevin ROwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-27,272Price:$137.96
-
Mar 28, 2024 (filed on Mar 29, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-100Price:$140.73
-
Mar 28, 2024 (filed on Mar 29, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,524Price:$140.02
-
Mar 25, 2024 (filed on Mar 26, 2024)Insider Name:Stern SadieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-4,137Price:$140.00
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,003Price:$131.39
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,314Price:$130.77
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,886Price:$129.18
Filings by filing date
-
Apr 30, 2024 (filed on May 02, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-629Price:$126.25
-
Apr 15, 2024 (filed on Apr 16, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,990Price:$137.81
-
Apr 08, 2024 (filed on Apr 10, 2024)Insider Name:Sayer Kevin ROwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-22,361Price:$138.71
-
Apr 08, 2024 (filed on Apr 10, 2024)Insider Name:Sayer Kevin ROwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-27,272Price:$137.96
-
Mar 28, 2024 (filed on Mar 29, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-100Price:$140.73
-
Mar 28, 2024 (filed on Mar 29, 2024)Insider Name:Brown Michael JonOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-2,524Price:$140.02
-
Mar 25, 2024 (filed on Mar 26, 2024)Insider Name:Stern SadieOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-4,137Price:$140.00
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,003Price:$131.39
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,314Price:$130.77
-
Mar 15, 2024 (filed on Mar 19, 2024)Insider Name:Dolan Matthew VincentOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,886Price:$129.18
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 6340 Sequence Dr SAN DIEGO CA 92121-4356 |
Tel: | N/A |
Website: | https://www.dexcom.com |
IR: | See website |
Key People | ||
Kevin R. Sayer Chairman of the Board, President, Chief Executive Officer | Teri Lawver Executive Vice President - Chief Commercial Officer | Jereme M. Sylvain Chief Financial Officer, Executive Vice President |
Jacob Steven Leach Executive Vice President, Chief Operating Officer | Sadie M. Stern Chief Human Resource Officer, Executive Vice President | Girish Naganathan Executive Vice President, Chief Technology Officer |
Steven R. Pacelli Executive Vice President, Managing Director - Dexcom Ventures | Donald M. Abbey Executive Vice President, Global Business Services, IT Quality and Regulatory Affairs | Michael Brown Executive Vice President, Chief Legal Officer | Matthew Vincent Dolan Executive Vice President - Strategy, Corporate Development and Dexcom Labs |
Business Overview |
DexCom, Inc. is a medical device company. The Company enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The Company is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The Company is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient's compatible mobile device. |
Financial Overview |
For the three months ended 31 March 2024, DexCom Inc revenues increased 24% to $921M. Net income increased from $48.6M to $146.4M. Revenues reflect Distributor segment increase of 26% to $778.8M, Direct segment increase of 16% to $142.2M, United States segment increase of 24% to $653.2M, Outside of United states segment increase of 24% to $267.8M. Basic Earnings per Share excluding Extraordinary Items increased from $0.13 to $0.38. |
Employees: | 9,600 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $51,156M as of Mar 31, 2024 |
Annual revenue (TTM): | $3,802M as of Mar 31, 2024 |
EBITDA (TTM): | $865.10M as of Mar 31, 2024 |
Net annual income (TTM): | $639.30M as of Mar 31, 2024 |
Free cash flow (TTM): | $583.50M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 397,683,837 as of Apr 18, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |